Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03260426 · ClinicalTrials.gov registry record · NA
Trial of Low Residue Diet Versus Clear Liquids Following Elective Colorectal Surgery
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03260426 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT03260426, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Prospective randomized controlled trial investigating commencement of low residue diet versus clear liquids on postoperative zero following elective colorectal surgery, with regards to patient tolerability, incidence of nausea and/or vomiting, and postoperative length of hospitalization stay.
Interventions
- DIETARY_SUPPLEMENT Clear Liquids
- DIETARY_SUPPLEMENT Regular Solid
- DEVICE Abstats
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-08-16 |
| Est. Completion | 2018-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03260426
The ClinicalTrials.gov registry entry for NCT03260426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clear Liquids is the first listed.
NCT03260426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03260426 about?
NCT03260426 is a clinical study titled "Trial of Low Residue Diet Versus Clear Liquids Following Elective Colorectal Surgery". Prospective randomized controlled trial investigating commencement of low residue diet versus clear liquids on postoperative zero following elective colorectal surgery, with regards to patient tolerability, incidence of nausea and/or vomiting, and postoperative length of hospitalization stay.
What is the current status of trial NCT03260426?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-08-16. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT03260426?
The interventions under investigation include: Clear Liquids (DIETARY_SUPPLEMENT), Regular Solid (DIETARY_SUPPLEMENT), Abstats (DEVICE).
Who is sponsoring clinical trial NCT03260426?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.